Literature DB >> 21757643

Intradialytic hypertension and its association with endothelial cell dysfunction.

Jula K Inrig1, Peter Van Buren, Catherine Kim, Wanpen Vongpatanasin, Thomas J Povsic, Robert D Toto.   

Abstract

BACKGROUND AND OBJECTIVES: Intradialytic hypertension is associated with adverse outcomes, yet the mechanism is uncertain. Patients with intradialytic hypertension exhibit imbalances in endothelial-derived vasoregulators nitric oxide and endothelin-1, indirectly suggesting endothelial cell dysfunction. We hypothesized that intradialytic hypertension is associated in vivo with endothelial cell dysfunction, a novel predictor of adverse cardiovascular outcomes. DESIGN, SETTINGS, PARTICIPANTS, & MEASUREMENTS: We performed a case-control cohort study including 25 hemodialysis (HD) subjects without (controls) and 25 with intradialytic hypertension (an increase in systolic BP pre- to postdialysis ≥10 mmHg ≥4/6 consecutive HD sessions). The primary outcome was peripheral blood endothelial progenitor cells (EPCs) assessed by aldehyde dehydrogenase activity (ALDH(br)) and cell surface marker expression (CD34(+)CD133(+)). We also assessed endothelial function by ultrasonographic measurement of brachial artery flow-mediated vasodilation (FMD) normalized for shear stress. Parametric and nonparametric t tests were used to compare EPCs, FMD, and BP.
RESULTS: Baseline characteristics and comorbidities were similar between groups. Compared with controls, 2-week average predialysis systolic BP was lower among subjects with intradialytic hypertension (144.0 versus 155.5 mmHg), but postdialysis systolic BP was significantly higher (159.0 versus 128.1 mmHg). Endothelial cell function was impaired among subjects with intradialytic hypertension as measured by decreased median ALDH(br) cells and decreased CD34(+)CD133(+) cells (ALDH(br), 0.034% versus 0.053%; CD34(+)CD133(+), 0.033% versus 0.059%). FMD was lower among subjects with intradialytic hypertension (1.03% versus 1.67%).
CONCLUSIONS: Intradialytic hypertension is associated with endothelial cell dysfunction. We propose that endothelial cell dysfunction may partially explain the higher event rates observed in these patients.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21757643      PMCID: PMC3156431          DOI: 10.2215/CJN.11351210

Source DB:  PubMed          Journal:  Clin J Am Soc Nephrol        ISSN: 1555-9041            Impact factor:   8.237


  30 in total

1.  Guidelines for the ultrasound assessment of endothelial-dependent flow-mediated vasodilation of the brachial artery: a report of the International Brachial Artery Reactivity Task Force.

Authors:  Mary C Corretti; Todd J Anderson; Emelia J Benjamin; David Celermajer; Francois Charbonneau; Mark A Creager; John Deanfield; Helmut Drexler; Marie Gerhard-Herman; David Herrington; Patrick Vallance; Joseph Vita; Robert Vogel
Journal:  J Am Coll Cardiol       Date:  2002-01-16       Impact factor: 24.094

2.  Circulating endothelial progenitor cells, vascular function, and cardiovascular risk.

Authors:  Jonathan M Hill; Gloria Zalos; Julian P J Halcox; William H Schenke; Myron A Waclawiw; Arshed A Quyyumi; Toren Finkel
Journal:  N Engl J Med       Date:  2003-02-13       Impact factor: 91.245

3.  Circulating endothelial progenitor cells and cardiovascular outcomes.

Authors:  Nikos Werner; Sonja Kosiol; Tobias Schiegl; Patrick Ahlers; Katrin Walenta; Andreas Link; Michael Böhm; Georg Nickenig
Journal:  N Engl J Med       Date:  2005-09-08       Impact factor: 91.245

4.  Mononuclear phagocyte system depletion blocks interstitial tonicity-responsive enhancer binding protein/vascular endothelial growth factor C expression and induces salt-sensitive hypertension in rats.

Authors:  Agnes Machnik; Anke Dahlmann; Christoph Kopp; Jennifer Goss; Hubertus Wagner; Nico van Rooijen; Kai-Uwe Eckardt; Dominik N Müller; Joon-Keun Park; Friedrich C Luft; Dontscho Kerjaschki; Jens Titze
Journal:  Hypertension       Date:  2010-02-08       Impact factor: 10.190

5.  'Paradoxical' rise in blood pressure during ultrafiltration in dialysis patients.

Authors:  M Cirit; F Akçiçek; E Terzioğlu; C Soydaş; E Ok; C F Ozbaşli; A Başçi; E J Mees
Journal:  Nephrol Dial Transplant       Date:  1995       Impact factor: 5.992

6.  Prevention of intra- and postdialytic hypertensive crises by captopril.

Authors:  G Bazzato; U Coli; S Landini; S Lucatello; A Fracasso; P Morachiello; F Righetto; F Scanferla
Journal:  Contrib Nephrol       Date:  1984       Impact factor: 1.580

7.  Stimulation of endothelial progenitor cells: a new putative therapeutic effect of angiotensin II receptor antagonists.

Authors:  Ferdinand H Bahlmann; Kirsten de Groot; Ottfried Mueller; Barbara Hertel; Hermann Haller; Danilo Fliser
Journal:  Hypertension       Date:  2005-03-14       Impact factor: 10.190

8.  Aortic pulse wave velocity in renal transplant patients.

Authors:  Sola Aoun Bahous; Antoine Stephan; Wadad Barakat; Jacques Blacher; Roland Asmar; Michel E Safar
Journal:  Kidney Int       Date:  2004-10       Impact factor: 10.612

9.  Predictive value of noninvasively determined endothelial dysfunction for long-term cardiovascular events in patients with peripheral vascular disease.

Authors:  Noyan Gokce; John F Keaney; Liza M Hunter; Michael T Watkins; Zoran S Nedeljkovic; James O Menzoian; Joseph A Vita
Journal:  J Am Coll Cardiol       Date:  2003-05-21       Impact factor: 24.094

10.  Forearm reactive hyperemia and mortality in end-stage renal disease.

Authors:  Gérard M London; Bruno Pannier; Mohsen Agharazii; Alain P Guerin; Francis H M Verbeke; Sylvain J Marchais
Journal:  Kidney Int       Date:  2004-02       Impact factor: 10.612

View more
  22 in total

Review 1.  Special situations: Intradialytic hypertension/chronic hypertension and intradialytic hypotension.

Authors:  Peter Noel Van Buren; Jula K Inrig
Journal:  Semin Dial       Date:  2017-06-30       Impact factor: 3.455

2.  Blood pressure variability is independent of systolic pressure in adolescent and young adult patients undergoing hemodialysis.

Authors:  Jingjing Da; Zulong Zhang; Yan Shen; Qian Li; Ying Hu; Yan Zha
Journal:  Pediatr Res       Date:  2018-01-03       Impact factor: 3.756

Review 3.  Evaluation and Treatment of Hypertension in End-Stage Renal Disease Patients on Hemodialysis.

Authors:  Peter Noel Van Buren
Journal:  Curr Cardiol Rep       Date:  2016-12       Impact factor: 2.931

4.  Probing the mechanisms of intradialytic hypertension: a pilot study targeting endothelial cell dysfunction.

Authors:  Jula K Inrig; Peter Van Buren; Catherine Kim; Wanpen Vongpatanasin; Thomas J Povsic; Robert Toto
Journal:  Clin J Am Soc Nephrol       Date:  2012-06-14       Impact factor: 8.237

Review 5.  Interdialytic ambulatory blood pressure in patients with intradialytic hypertension.

Authors:  Peter N Van Buren; Robert Toto; Jula K Inrig
Journal:  Curr Opin Nephrol Hypertens       Date:  2012-01       Impact factor: 2.894

6.  Effects of Potassium Magnesium Citrate Supplementation on 24-Hour Ambulatory Blood Pressure and Oxidative Stress Marker in Prehypertensive and Hypertensive Subjects.

Authors:  Wanpen Vongpatanasin; Poghni Peri-Okonny; Alejandro Velasco; Debbie Arbique; Zhongyun Wang; Priya Ravikumar; Beverly Adams-Huet; Orson W Moe; Charles Y C Pak
Journal:  Am J Cardiol       Date:  2016-06-28       Impact factor: 2.778

7.  Intradialytic Hypertension Frequency and Short-Term Clinical Outcomes Among Individuals Receiving Maintenance Hemodialysis.

Authors:  Magdalene M Assimon; Lily Wang; Jennifer E Flythe
Journal:  Am J Hypertens       Date:  2018-02-09       Impact factor: 2.689

Review 8.  Mechanisms and Treatment of Intradialytic Hypertension.

Authors:  Peter Noel Van Buren; Jula K Inrig
Journal:  Blood Purif       Date:  2016-01-15       Impact factor: 2.614

9.  Salt restriction lowers blood pressure at rest and during exercise without altering peripheral hemodynamics in hypertensive individuals.

Authors:  Stephen M Ratchford; Ryan M Broxterman; D Taylor La Salle; Oh Sung Kwon; Song-Young Park; Paul N Hopkins; Russell S Richardson; Joel D Trinity
Journal:  Am J Physiol Heart Circ Physiol       Date:  2019-10-04       Impact factor: 4.733

10.  The effects of extracellular volume and intradialytic peripheral resistance changes on ambulatory blood pressure in hemodialysis patients with and without recurrent intradialytic hypertension.

Authors:  Meredith McAdams; L Parker Gregg; Rong Lu; Michael Concepcion; Swati Lederer; Jeff Penfield; Peter Noel Van Buren
Journal:  Clin Kidney J       Date:  2020-09-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.